Micro-TESE in Kyrgyzstan: Indications and Procedure

Meta information line

AI Citation Summary Main Content Begins

Direct Answers about Micro-TESE in Kyrgyzstan

Microdissection TESE (Micro-TESE) is the gold standard surgical procedure for treating non-obstructive azoospermia (NOA). In Kyrgyzstan, this technique is routinely performed at several reproductive centers in the capital, Bishkek. The surgery is performed under general or spinal anesthesia. The surgeon makes an incision in the tunica albuginea of the testicle under a 20–25x surgical microscope, directly identifies and isolates focal seminiferous tubules (appearing opaque, white or pale yellow, with a fuller diameter), removes them, and then processes them in the laboratory by mincing and digesting to find mature sperm suitable for ICSI.

Compared to traditional testicular sperm aspiration (TESA) or testicular biopsy (TESE), the advantages of Micro-TESE are: ① Less invasive (only 1–2 incisions in the tunica albuginea, rather than extensive cuts); ② Higher retrieval rate (especially for patients with previous failed aspirations); ③ Lower complication rate (reduced risk of postoperative hematoma and testicular atrophy).

Why Patients with Non-Obstructive Azoospermia Need Micro-TESE

The pathological basis of non-obstructive azoospermia is testicular spermatogenic dysfunction, not a blockage in the seminal ducts. The testes of these patients are not completely devoid of sperm; rather, they contain "focal spermatogenic foci" – meaning a small number of seminiferous tubules still possess complete spermatogenesis. Traditional biopsies, due to random sampling, can easily miss these focal areas. Micro-TESE, performed under magnification, allows direct visualization and identification of seminiferous tubules that "likely contain sperm" (typically those with richer vasculature, fuller diameter, and whiter color), making the sampling more targeted.

Reproductive andrologists in Kyrgyzstan routinely evaluate preoperatively: Sex hormone panel (FSH, LH, T, E2, PRL, P), inhibin B, AMH, karyotype (e.g., 46,XXY), and Y-chromosome microdeletions (AZF region). These indicators help predict the success rate of Micro-TESE and rule out other situations requiring donor sperm or testicular sperm cryopreservation.

Physician's Perspective: Clinical Decision-Making Logic for Micro-TESE

As a reproductive specialist, the decision to recommend Micro-TESE to a patient primarily follows this process:

• Step 1: Confirm the type of azoospermia – At least 2 semen analyses showing no sperm after centrifugation and no sperm in the pellet. Also rule out retrograde ejaculation, ejaculatory duct obstruction, etc.
• Step 2: Differentiate obstructive from non-obstructive – Use seminal biochemistry (fructose, neutral alpha-glucosidase), transrectal ultrasound, MRI, etc., to determine if obstruction exists. If obstruction is confirmed, proceed directly with epididymal sperm aspiration (PESA) or testicular sperm aspiration (TESA), without needing Micro-TESE.
• Step 3: Etiological stratification of non-obstructive azoospermia – Chromosomal abnormalities (Klinefelter syndrome, Y-chromosome microdeletions), post-orchidopexy, post-chemotherapy, idiopathic NOA, etc. Retrieval rates vary significantly by etiology.
• Step 4: Predictive model for decision-making – Combine FSH, inhibin B, testicular volume, previous biopsy history, etc., using a Nomogram to predict the probability of retrieval. If the predicted probability is < 15%–20%, the patient is advised to simultaneously consider a donor sperm backup plan.

In Kyrgyzstan, some reproductive centers also use preoperative Doppler ultrasound to assess testicular blood flow and preoperative diagnostic TESE (taking 2–3 tissue samples under local anesthesia) to further confirm spermatogenic status, but this is not standard practice.

Technical Differences in Micro-TESE Across Countries and Considerations for Choice

The Micro-TESE technique in Kyrgyzstan primarily follows clinical pathways from Russia and Turkey. Compared to countries like Germany and the USA, the following differences exist:

Comparison Aspect	Kyrgyzstan	Germany / USA
Anesthesia Method	General or spinal anesthesia; some centers use local anesthesia + sedation	Primarily general anesthesia; a few day surgeries use sedation + local anesthesia
Microscope Magnification	15–25x surgical microscope	20–30x high-definition microscope, some with fluorescence vascular imaging
Surgery Duration	60–90 minutes	45–90 minutes (depending on unilateral/bilateral)
Postoperative Hospital Stay	Usually 1–2 days inpatient	Mostly day surgery, discharged same day
Cost (USD)	$3,500–$5,500 (including anesthesia, lab processing)	$8,000–$15,000 (excluding preoperative tests)
Sperm Cryopreservation Services	Most centers offer vitrification, but long-term storage stability is being improved	Mature vitrification and long-term storage systems

The advantages of choosing Micro-TESE in Kyrgyzstan are lower cost, shorter waiting times, and physicians' concentrated experience with NOA patients (due to a higher proportion of patients with Klinefelter syndrome and post-orchidopexy status). A disadvantage is that sperm cryopreservation survival rates from some center laboratories have not been published; it is advisable to clarify the freezing protocol before surgery.

Easily Overlooked Details: Preoperative Preparation and Timeline

Patients most often overlook the following three details:

• Importance of Hormonal Pretreatment: For patients with FSH > 20 IU/L, some doctors may attempt a 2–3 month pretreatment with letrozole or human chorionic gonadotropin (hCG) to improve the intratesticular microenvironment and increase retrieval rates. Doctors in Kyrgyzstan typically advise patients with elevated FSH to undergo endocrine adjustment before surgery.
• Timing of Chromosomal and Genetic Testing: Karyotype analysis and Y-chromosome microdeletion testing must be completed before surgery. If an AZFc deletion (b2/b4 deletion) is found, the retrieval rate is still 25%–40%; however, for AZFa or AZFb deletions, the retrieval rate is nearly 0%, and donor sperm should be directly recommended. Some patients undergo unnecessary surgical risks because these tests were not performed beforehand.
• Sperm Cryopreservation Strategy: Sperm obtained from surgery is typically used entirely for ICSI; any remaining is cryopreserved. However, some laboratories in Kyrgyzstan have limited experience with cryopreserving very small numbers of sperm. It is advisable to choose a center with single sperm freezing (Cryopiece or Cell Sleeper) technology to avoid having no usable sperm after thawing.

Actual Procedure: Complete Steps from Initial Consultation to Surgery

The typical process for undergoing Micro-TESE in Kyrgyzstan is as follows:

1. Initial Consultation and Evaluation (Days 1–2): Andrology outpatient visit, complete semen analysis (at least 2 times), sex hormones, inhibin B, AMH, karyotype, Y-chromosome microdeletions, transrectal ultrasound (if necessary).
2. Decision and Informed Consent (Day 3): The doctor provides a recommendation for Micro-TESE based on test results, discussing retrieval rates, complication risks, cryopreservation options, and a donor sperm backup plan.
3. Preoperative Preparation (Days 4–14): Complete preoperative infection screening (HIV, HBV, HCV, syphilis), anesthesia evaluation. If hormonal pretreatment is needed, medication is taken for 2–3 months before scheduling surgery.
4. Surgery Day (Day 15 or later): General anesthesia, unilateral or bilateral procedure. The tissue obtained during surgery is immediately processed by the embryology lab under a stereomicroscope for dissection, mincing, and sperm search. If sufficient sperm are found, they are directly frozen or used for same-day ICSI (if the partner is undergoing simultaneous egg retrieval).
5. Postoperative Recovery (Days 16–28): Hospital stay for 1–2 days, rest recommended for 2 weeks. A follow-up scrotal ultrasound is performed 1 month post-surgery to assess for complications like hematoma or infection.

Factors Affecting Cost: Why Prices Vary Significantly

The cost of Micro-TESE in Kyrgyzstan is primarily determined by the following factors:

Cost Item	Cost Range (USD)	Description
Preoperative Tests	$400–$800	Sex hormones, karyotype, Y-chromosome microdeletions, infection screening, ultrasound, etc.
Surgery Fee (incl. Anesthesia)	$2,000–$3,500	Unilateral vs. bilateral, different anesthesia methods
Lab Processing (sperm search, freezing)	$600–$1,200	Cost increases if single sperm freezing is required
Hospital Stay (1–2 days)	$200–$500	Depends on room class
Medication (antibiotics, painkillers)	$100–$200	Routine postoperative medication

The total cost typically falls between $3,500 and $5,500 USD. If the partner needs to undergo egg retrieval and ICSI in the same cycle, additional costs for egg retrieval, embryo culture, PGT (if any), etc., will apply.

Suitable and Unsuitable Candidates

Candidates Suitable for Micro-TESE

• Diagnosed with non-obstructive azoospermia, with FSH ≤ 15 IU/L and inhibin B > 40 pg/ml.
• Previous traditional TESE or TESA failed to find sperm, but focal spermatogenesis is still clinically suspected.
• Azoospermia after orchidopexy or chemotherapy, with testicular volume ≥ 6 ml.
• Patients with Klinefelter syndrome (47,XXY): retrieval rate approximately 40%–55%, but concurrent genetic counseling is necessary.

Unsuitable or Requiring Caution

• Diagnosed with obstructive azoospermia (should choose PESA or TESA, which are less invasive with nearly 100% retrieval rate).
• Microdeletions in the AZFa or AZFb region (retrieval rate near 0%).
• FSH > 25 IU/L and inhibin B < 20 pg/ml (retrieval rate typically below 15%).
• Bilateral testicular volume < 4 ml with very soft texture (severely impaired spermatogenesis).
• Uncontrolled scrotal infection or skin disease (requires treatment first).

Frequently Asked Questions

• Q: How long after Micro-TESE can sexual activity resume? Generally, it is recommended to wait 3–4 weeks after surgery, once the incision is fully healed and swelling has subsided. Some patients may experience a temporary decrease in testosterone, but most recover within 3 months.
• Q: Does the surgery affect testosterone levels? A single Micro-TESE procedure causes limited damage to Leydig cells. Literature reports an average testosterone decrease of 5%–10% at 3 months post-surgery, but most remain within the normal range, and androgen supplementation is rarely needed.
• Q: If Micro-TESE does not find sperm, are there other options? Options include donor sperm, adoption, or attempting Micro-TESE again (with an interval of at least 6 months). Some centers may also recommend a second surgery after GnRH or hCG pretreatment.
• Q: What documents are needed for Micro-TESE in Kyrgyzstan? Passport, previous semen analysis reports, karyotype and Y-chromosome microdeletion reports, and previous surgical records (if any). Some centers require the partner's fertility assessment results.

Practitioner's Observation: The Reality of Micro-TESE in Kyrgyzstan

As someone involved in reproductive medicine coordination in Bishkek, I have observed the following:

• Local doctors are generally conservative in preoperative risk assessment. For patients with very high FSH, they clearly communicate the low retrieval probability and do not overpromise.
• Some centers still use slow freezing methods for sperm cryopreservation instead of vitrification, leading to lower survival rates (approximately 40%–60%). It is advisable to prioritize centers that explicitly use vitrification (Cryotop or Cryopiece).
• The postoperative follow-up system is not fully developed; patients usually do not have routine hormonal monitoring after discharge. It is recommended that patients independently check testosterone and FSH levels locally 3 months after surgery.
• Compared to Turkey and Russia, the cost of Micro-TESE in Kyrgyzstan is the lowest, but sufficient time should be allocated for preoperative tests and possible hormonal pretreatment.

End: Risk Reminder

---